105 related articles for article (PubMed ID: 17496445)
1. [A feasible study of docetaxel/nedaplatin combined chemotherapy for relapsed or refractory esophageal cancer patients as a 2nd-line chemotherapy].
Matsumoto H; Hirai T; Hirabayashi Y; Murakami H; Higashida M; Kawabe Y; Urakami A; Yamashita K; Tsunoda T
Gan To Kagaku Ryoho; 2007 May; 34(5):725-8. PubMed ID: 17496445
[TBL] [Abstract][Full Text] [Related]
2. Phase I Study of Docetaxel Plus Nedaplatin in Patients With Metastatic or Recurrent Esophageal Squamous Cell Carcinoma After Cisplatin Plus 5-Fluorouracil Treatment.
Kajiura S; Hosokawa A; Yoshita H; Ueda Y; Ueda A; Mihara H; Ando T; Fujinami H; Nishikawa J; Ogawa K; Minemura M; Sugiyama T
Am J Clin Oncol; 2016 Feb; 39(1):13-7. PubMed ID: 24322336
[TBL] [Abstract][Full Text] [Related]
3. Dose escalation study of docetaxel and nedaplatin in patients with relapsed or refractory squamous cell carcinoma of the esophagus pretreated using cisplatin, 5-fluorouracil, and radiation.
Yoshioka T; Sakayori M; Kato S; Chiba N; Miyazaki S; Nemoto K; Shibata H; Shimodaira H; Ohtsuka K; Kakudo Y; Sakata Y; Ishioka C
Int J Clin Oncol; 2006 Dec; 11(6):454-60. PubMed ID: 17180514
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of combination chemotherapy with docetaxel and nedaplatin in patients with advanced or recurrent esophageal cancer].
Funaki H; Miura S; Morioka E; Kaida D; Ohnishi T; Ohno Y; Tomita Y; Noguchi M; Fujita H; Kinami S; Nakano Y; Ueda N; Kosaka T
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2384-6. PubMed ID: 25731531
[TBL] [Abstract][Full Text] [Related]
5. Combination chemotherapy with docetaxel and nedaplatin for recurrent esophageal cancer in an outpatient setting.
Osaka Y; Takagi Y; Hoshino S; Tachibana S; Tsuchida A; Aoki T
Dis Esophagus; 2006; 19(6):473-6. PubMed ID: 17069591
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of combined docetaxel and nedaplatin chemotherapy for recurrent esophageal cancer compared with conventional chemotherapy using cisplatin and 5-fluorouracil: a retrospective study.
Fujita Y; Hiramatsu M; Kawai M; Sumiyoshi K; Nishimura H; Tanigawa N
Dis Esophagus; 2008; 21(6):496-501. PubMed ID: 18840134
[TBL] [Abstract][Full Text] [Related]
7. A pilot trial of docetaxel and nedaplatin in cisplatin-pretreated relapsed or refractory esophageal squamous cell cancer.
Nakajima Y; Suzuki T; Haruki S; Ogiya K; Kawada K; Nishikage T; Nagai K; Kawano T
Hepatogastroenterology; 2008; 55(86-87):1631-5. PubMed ID: 19102357
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of combination chemotherapy with docetaxel and nedaplatin for esophageal cancer].
Kawada J; Iwase K; Deguchi K; Higashi S; Deguchi T; Matsuda C; Tamagawa H; Omori K; Nishikawa K; Nomura M; Takagi M; Fukui A; Tanaka Y
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2095-7. PubMed ID: 23267988
[TBL] [Abstract][Full Text] [Related]
9. A combined therapy with docetaxel and nedaplatin for relapsed and metastatic esophageal carcinoma.
Matsumoto H; Hirabayashi Y; Kubota H; Murakami H; Higashida M; Haruma K; Hiratsuka J; Nakamura M; Hirai T
Anticancer Res; 2012 May; 32(5):1827-31. PubMed ID: 22593469
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Biweekly Docetaxel in Combination with Nedaplatin as Second-line Chemotherapy for Unresectable or Recurrent Esophageal Cancer.
Kanekiyo S; Takeda S; Nakajima M; Nishiyama M; Kitahara M; Shindou Y; Michihisa I; Abe T; Yoshino S; Hazama S; Nagano H
Anticancer Res; 2016 Apr; 36(4):1923-7. PubMed ID: 27069181
[TBL] [Abstract][Full Text] [Related]
11. Second-line combination chemotherapy with docetaxel and nedaplatin for Cisplatin-pretreated refractory metastatic/recurrent esophageal squamous cell carcinoma.
Jin J; Xu X; Wang F; Yan G; Liu J; Lu W; Li X; Tucker SJ; Zhong B; Cao Z; Wang D
J Thorac Oncol; 2009 Aug; 4(8):1017-21. PubMed ID: 19542899
[TBL] [Abstract][Full Text] [Related]
12. [A case of advanced esophageal cancer with multiple lymph node metastases successfully treated with induction chemotherapy consisting of nedaplatin and 5-FU followed by chemoradiotherapy].
Sasaki T; Nakamura K; Toba T; Kimura M; Ohga S; Urashima Y; Terashima H; Masuda K
Gan To Kagaku Ryoho; 2002 Aug; 29(8):1417-20. PubMed ID: 12214470
[TBL] [Abstract][Full Text] [Related]
13. [Clinical study of the combination of small amount of nedaplatin (CDGP)/5-FU with radiation for the treatment of esophageal cancer].
Inaba H; Tsuda T; Miyazaki A; Watanabe Y; Nakaya S; Koitabashi Y; Ogihara K; Hara T; Kato N; Kobayashi Y; Nakagawa T; Kitajima S; Endo T; Iino S; Hoshikawa Y
Nihon Shokakibyo Gakkai Zasshi; 2002 Oct; 99(10):1191-6. PubMed ID: 12415854
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and feasibility of ambulatory treatment-based monthly nedaplatin plus S-1 in definitive or salvage concurrent chemoradiotherapy for early, advanced, and relapsed esophageal cancer.
Yamashita H; Haga A; Takenaka R; Kiritoshi T; Okuma K; Ohtomo K; Nakagawa K
Radiat Oncol; 2016 Jan; 11():4. PubMed ID: 26781439
[TBL] [Abstract][Full Text] [Related]
15. Radiation therapy combined with cis-diammine-glycolatoplatinum (Nedaplatin) and 5-fluorouracil for untreated and recurrent esophageal cancer.
Nemoto K; Matsushita H; Ogawa Y; Takeda K; Takahashi C; Britton KR; Takai Y; Miyazaki S; Miyata T; Yamada S
Am J Clin Oncol; 2003 Feb; 26(1):46-9. PubMed ID: 12576924
[TBL] [Abstract][Full Text] [Related]
16. [Pathologic complete response of thoracic esophageal cancer developing after gastrectomy to neoadjuvant low-dose nedaplatin (CDGP), 5-fluorouracil and radiotherapy].
Takemura M; Osugi H; Lee S; Nishikawa T; Fukuhara K; Iwasaki H
Gan To Kagaku Ryoho; 2005 Jul; 32(7):1023-7. PubMed ID: 16044966
[TBL] [Abstract][Full Text] [Related]
17. [Prospective non-randomized study of chemotherapy combined with radiotherapy versus chemotherapy alone in patients with metastatic or relapsed esophageal squamous cell carcinoma].
Zhang XD; Shen L; Li J; Li Y; Li J; Zhang XT; Jin ML
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):474-7. PubMed ID: 17974288
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of docetaxel, CDDP and 5-FU combined therapy as second-line chemotherapy for esophagus cancer].
Minamide J; Aoyama N; Takada K; Oota Y
Gan To Kagaku Ryoho; 2007 Jan; 34(1):49-52. PubMed ID: 17220669
[TBL] [Abstract][Full Text] [Related]
19. [A resected case of thoracic esophageal cancer in which pCR was obtained using low-dose of nedaplatin (CDGP)/5-FU and radiotherapy].
Takemura M; Osugi H; Lee S; Kaneko M; Tanaka Y; Fujiwara Y; Nishizawa S; Iwasaki H; Higashino M
Gan To Kagaku Ryoho; 2004 Sep; 31(9):1399-402. PubMed ID: 15446565
[TBL] [Abstract][Full Text] [Related]
20. [A case of recurrent esophageal cancer successfully treated with concurrent radiochemotherapy with low-dose docetaxel plus 5-FU].
Shibata T; Takeno S; Watanabe S; Fumoto S; Takahashi Y; Noguchi T; Kawahara K
Gan To Kagaku Ryoho; 2007 Jul; 34(7):1119-21. PubMed ID: 17637553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
